Table of Contents
Journal of Cancer Research
Volume 2015, Article ID 980214, 8 pages
http://dx.doi.org/10.1155/2015/980214
Research Article

CXCR4 Expression in Gastric Cancer and Bone Marrow: Association with Hypoxia-Regulated Indices, Disseminated Tumor Cells, and Patients Survival

1City Clinical Oncological Center, Verchovynna Street 69, Kiev 03115, Ukraine
2R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Vasylkivska Street 45, Kiev 03022, Ukraine

Received 20 September 2014; Revised 27 January 2015; Accepted 27 January 2015

Academic Editor: Daizo Yoshida

Copyright © 2015 Dmitry Osinsky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Zhang, C. Ni, W. Chen et al., “Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis,” BMC Cancer, vol. 14, article 49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-P. Jiang, X.-H. Wu, B. Shi, W.-X. Wu, and G.-R. Yin, “Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression,” Gynecologic Oncology, vol. 103, no. 1, pp. 226–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Scala, A. Ottaiano, P. A. Ascierto et al., “Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma,” Clinical Cancer Research, vol. 11, no. 5, pp. 1835–1841, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. X. W. Bian, S. X. Yang, J. H. Chen, and et al, “Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival,” Neurosurgery, vol. 61, no. 3, pp. 570–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. J. Jung, C. Kim Il, C. H. Park et al., “Correlation between chemokine receptor CXCR4 expression and prognostic factors in patients with prostate cancer,” Korean Journal of Urology, vol. 52, no. 9, pp. 607–611, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. T. Kaifi, E. F. Yekebas, P. Schurr et al., “Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer,” Journal of the National Cancer Institute, vol. 97, no. 24, pp. 1840–1847, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-L. Xiang, Z.-C. Zeng, Z.-Y. Tang et al., “Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival,” BMC Cancer, vol. 9, article 176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Koshiba, R. Hosotani, Y. Miyamoto et al., “Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression,” Clinical Cancer Research, vol. 6, no. 9, pp. 3530–3535, 2000. View at Google Scholar · View at Scopus
  9. M. Zhang, K. Iqbal, and S. Yu, “Positive expression and correlation of chemokine receptor CXCR4 with nodal metastasis and prognosis in colorectal cancer,” The Chinese-German Journal of Clinical Oncology, vol. 6, no. 6, pp. 552–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. An, L. Xu, Y. Zhu et al., “High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma,” British Journal of Cancer, vol. 110, no. 9, pp. 2261–2268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Retz, S. S. Sidhu, E. Blaveri et al., “CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells,” International Journal of Cancer, vol. 114, no. 2, pp. 182–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Geminder, O. Sagi-Assif, L. Goldberg et al., “A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma,” The Journal of Immunology, vol. 167, no. 8, pp. 4747–4757, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. T. N. Hartmann, J. A. Burger, A. Glodek, N. Fujii, and M. Burger, “CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells,” Oncogene, vol. 24, no. 27, pp. 4462–4471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Andre, W. Xia, R. Conforti et al., “CXCR4 expression in early breast cancer and risk of distant recurrence,” The Oncologist, vol. 14, no. 12, pp. 1182–1188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Iwasa, T. Yanagawa, J. Fan, and R. Katoh, “Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis,” Anticancer Research, vol. 29, no. 11, pp. 4751–4758, 2009. View at Google Scholar · View at Scopus
  16. H. J. Lee, S. W. Kim, H. Y. Kim et al., “Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer,” International Journal of Oncology, vol. 34, no. 2, pp. 473–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Osinsky, A. Kovelskaya, L. Bubnovskaya et al., “Expression of CXCR4 in tumor and bone marrow of gastric cancer patients: association with hypoxia-regulated indices, disseminated tumor cells and survival,” Annals of Oncology, vol. 25, supplement 4, p. 222, 2014, 649P Abstract of the ESMO 2014 Congress, Madrid, Spain 26–30 September, 2014. View at Google Scholar
  18. K. Yasumoto, K. Koizumi, A. Kawashima et al., “Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer,” Cancer Research, vol. 66, no. 4, pp. 2181–2187, 2006. View at Publisher · View at Google Scholar
  19. I. Hashimoto, K. Koizumi, M. Tatematsu et al., “Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells,” European Journal of Cancer, vol. 44, no. 7, pp. 1022–1029, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Zieker, I. Königsrainer, F. Traub et al., “PGK1 a potential marker for peritoneal dissemination in gastric cancer,” Cellular Physiology and Biochemistry, vol. 21, no. 5-6, pp. 429–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B.-C. Zhao, Z.-J. Wang, W.-Z. Mao et al., “CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma,” World Journal of Gastroenterology, vol. 17, no. 19, pp. 2389–2396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Zhao, X. Lu, X. Bu, N. Zhang, and W. Wang, “Involvement of tumor necrosis factor-α in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori,” BMC Cancer, vol. 10, article no. 419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Lee, S. M. Huang, H. Y. Kim et al., “Evaluation of the combined expression of chemokine SDF-1α and its receptor CXCR4 as a prognostic marker for gastric cancer,” Experimental and Therapeutic Medicine, vol. 2, no. 3, pp. 499–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Nikzaban, M. S. Hakhamaneshi, S. Fakhari et al., “The chemokine receptor CXCR4 is associated with the staging of gastric cancer,” Advanced in Biomedical Research, vol. 3, no. 1, article 16, 2014. View at Publisher · View at Google Scholar
  25. B. Nikkhoo, A. Jalili, S. Fakhari et al., “Nuclear pattern of CXCR4 expression is associated with a better overall survival in patients with gastric cancer,” Journal of Oncology, vol. 2014, Article ID 808012, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-P. Spano, F. Andre, L. Morat et al., “Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome,” Annals of Oncology, vol. 15, no. 4, pp. 613–617, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. K. Mi, K. Hur, D. J. Park et al., “Expression of chemokine receptors in human gastric cancer,” Tumor Biology, vol. 26, no. 2, pp. 65–70, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Tsuboi, Y. Kodera, H. Nakanishi et al., “Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis,” Oncology Reports, vol. 20, no. 5, pp. 1117–1123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Ingold, E. Simon, U. Ungethüm et al., “Vascular CXCR4 expression—a novel antiangiogenic target in gastric cancer?” PLoS ONE, vol. 5, no. 4, Article ID e10087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Bernards, “Cues for migration,” Nature, vol. 425, no. 6955, pp. 247–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E. J. Oakeley, and W. Krek, “Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL,” Nature, vol. 425, no. 6955, pp. 307–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. International Union Against Cancer, TNM Classification of Malignant Tumors, edited by L.H. Sobin and C. Wittekind, Wiley-Liss, New York, NY, USA, 6th edition, 2002.
  33. C. Fenoglio-Preiser, F. Carneiro, P. Correa et al., “Gastric carcinoma,” in World Health Organization Clasificaiton of Tumors. Tumors of the Stomach, S. R. Hamilton and L. A. Aaltonen, Eds., vol. 3, chapter 3, pp. 39–52, IARC Press, Lyon, France, 2000. View at Google Scholar
  34. S. Osinsky, L. Bubnovskaya, I. Ganusevich et al., “Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival,” Clinical and Translational Oncology, vol. 13, no. 2, pp. 133–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Schioppa, B. Uranchimeg, A. Saccani et al., “Regulation of the chemokine receptor CXCR4 by hypoxia,” Journal of Experimental Medicine, vol. 198, no. 9, pp. 1391–1402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. P. A. Cronin, J. H. Wang, and H. P. Redmond, “Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4,” BMC Cancer, vol. 10, article 225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Bubnovskaya, A. Kovelskaya, L. Gumenyuk et al., “Disseminated tumor cells in bone marrow of gastric cancer patients: correlation with tumor hypoxia and clinical relevance,” Journal of Oncology, vol. 2014, Article ID 582140, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Pituch-Noworolska, G. Drabik, R. Szatanek et al., “Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer,” Polish Journal of Pathology, vol. 58, no. 2, pp. 93–97, 2007. View at Google Scholar · View at Scopus
  39. C. F. Chantrain, O. Feron, E. Marbaix, and Y. A. Declerck, “Bone marrow microenvironment and tumor progression,” Cancer Microenvironment, vol. 1, no. 1, pp. 23–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Zhang, H. Yeger, B. Das, M. S. Irwinz, and S. Baruchel, “Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma,” Neoplasia, vol. 9, no. 1, pp. 36–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Müller, B. Homey, H. Soto et al., “Involvement of chemokine receptors in breast cancer metastasis,” Nature, vol. 410, no. 6824, pp. 50–56, 2001. View at Publisher · View at Google Scholar · View at Scopus